[-] Show simple item record

dc.contributor.authorKirley, Kateeng
dc.contributor.authorNguyen, Lizeng
dc.contributor.otherFamily Physicians Inquiries Networkeng
dc.date.issued2014eng
dc.description.abstractMDIs with spacers are as effective as nebulizers for delivering beta-agonists and less likely to cause adverse effects. Practice changer: Stop ordering nebulizers to deliver beta-agonists to patients over age 2 with mild or moderate asthma exacerbations. A metered-dose inhaler (MDI) with a spacer produces the same benefits with fewer adverse effects.eng
dc.identifier.urihttp://hdl.handle.net/10355/43447
dc.languageEnglisheng
dc.publisherFamily Physicians Inquiries Networkeng
dc.relation.ispartofcollectionPriority Updates to Research Literature (PURLs) (2014)eng
dc.relation.ispartofcommunityUniversity of Missouri-Columbia. School of Medicine. Department of Family and Community Medicine. Family Physicians Inquiries Networkeng
dc.relation.ispartofseriesJournal of family practice, 63, no. 06 (June 2014): 321-322.eng
dc.rightsOpenAccess.eng
dc.rights.licenseThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 License.eng
dc.subject.otherAsthmaeng
dc.subject.otherNebulizerseng
dc.subject.otherMetered dose inhalereng
dc.subject.otherBeta-agonistseng
dc.titleThink twice about nebulizers for asthma attackseng
dc.typeArticleeng


Files in this item

[PDF]

This item appears in the following Collection(s)

[-] Show simple item record